Technical Analysis for PRCT - PROCEPT BioRobotics Corporation
Grade | Last Price | % Change | Price Change |
---|---|---|---|
A | 64.31 | 4.16% | 2.57 |
PRCT closed up 4.16 percent on Friday, May 3, 2024, on 1.97 times normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
New 52 Week High | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% |
Alert | Time |
---|---|
Up 5% | 3 days ago |
Up 1 ATR | 3 days ago |
Possible Pocket Pivot | 3 days ago |
2x Volume Pace | 3 days ago |
60 Minute Opening Range Breakout | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/04/2024
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is based in Redwood City, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine IBD 50 Urology Benign Prostatic Hyperplasia Minimally Invasive Surgery Robot Assisted Surgery Bph Urologic Surgery
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine IBD 50 Urology Benign Prostatic Hyperplasia Minimally Invasive Surgery Robot Assisted Surgery Bph Urologic Surgery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 64.89 |
52 Week Low | 24.83 |
Average Volume | 579,739 |
200-Day Moving Average | 40.26 |
50-Day Moving Average | 50.24 |
20-Day Moving Average | 53.31 |
10-Day Moving Average | 55.32 |
Average True Range | 3.11 |
RSI (14) | 78.40 |
ADX | 21.45 |
+DI | 38.01 |
-DI | 10.55 |
Chandelier Exit (Long, 3 ATRs) | 55.56 |
Chandelier Exit (Short, 3 ATRs) | 54.89 |
Upper Bollinger Bands | 61.15 |
Lower Bollinger Band | 45.47 |
Percent B (%b) | 1.2 |
BandWidth | 29.43 |
MACD Line | 2.83 |
MACD Signal Line | 1.61 |
MACD Histogram | 1.2187 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 70.64 | ||||
Resistance 3 (R3) | 70.13 | 67.51 | 69.59 | ||
Resistance 2 (R2) | 67.51 | 65.90 | 67.77 | 69.23 | |
Resistance 1 (R1) | 65.91 | 64.90 | 66.71 | 66.42 | 68.88 |
Pivot Point | 63.29 | 63.29 | 63.69 | 63.55 | 63.29 |
Support 1 (S1) | 61.69 | 61.68 | 62.49 | 62.20 | 59.74 |
Support 2 (S2) | 59.07 | 60.68 | 59.33 | 59.39 | |
Support 3 (S3) | 57.47 | 59.07 | 59.04 | ||
Support 4 (S4) | 57.98 |